HealthEquity (NASDAQ:HQY) Cut to “Hold” at Wall Street Zen

Wall Street Zen downgraded shares of HealthEquity (NASDAQ:HQY) from a buy rating to a hold rating in a research report report published on Sunday.

Other analysts also recently issued research reports about the company. BTIG Research reissued a “buy” rating and issued a $130.00 price target on shares of HealthEquity in a report on Thursday, December 4th. Barclays started coverage on shares of HealthEquity in a report on Monday, December 8th. They set an “overweight” rating and a $118.00 price target for the company. BMO Capital Markets restated a “market perform” rating on shares of HealthEquity in a research report on Thursday, December 4th. Weiss Ratings reiterated a “hold (c+)” rating on shares of HealthEquity in a research report on Wednesday, October 8th. Finally, Barrington Research restated an “outperform” rating and issued a $125.00 target price on shares of HealthEquity in a research report on Thursday, December 4th. Two research analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, HealthEquity presently has an average rating of “Moderate Buy” and an average price target of $119.60.

HealthEquity Trading Down 0.3%

NASDAQ HQY opened at $84.28 on Friday. HealthEquity has a one year low of $74.07 and a one year high of $116.65. The company has a 50-day simple moving average of $96.62 and a 200-day simple moving average of $94.85. The company has a debt-to-equity ratio of 0.46, a quick ratio of 4.13 and a current ratio of 4.13. The firm has a market capitalization of $7.20 billion, a PE ratio of 38.66, a price-to-earnings-growth ratio of 1.22 and a beta of 0.20.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.11. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The firm had revenue of $322.16 million for the quarter, compared to analyst estimates of $320.92 million. During the same quarter in the prior year, the business earned $0.78 earnings per share. HealthEquity’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. On average, equities analysts forecast that HealthEquity will post 2.32 earnings per share for the current year.

Insider Buying and Selling

In related news, EVP Elimelech Rosner sold 10,959 shares of the firm’s stock in a transaction that occurred on Thursday, December 18th. The shares were sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the transaction, the executive vice president owned 45,742 shares in the company, valued at $4,366,073.90. This trade represents a 19.33% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Delano Ladd sold 1,500 shares of the company’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $94.72, for a total value of $142,080.00. Following the completion of the sale, the executive vice president owned 73,979 shares of the company’s stock, valued at $7,007,290.88. This trade represents a 1.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 15,459 shares of company stock worth $1,483,062 in the last quarter. Company insiders own 1.50% of the company’s stock.

Institutional Investors Weigh In On HealthEquity

A number of institutional investors and hedge funds have recently modified their holdings of HQY. Vanguard Group Inc. raised its holdings in HealthEquity by 2.9% during the 3rd quarter. Vanguard Group Inc. now owns 8,746,255 shares of the company’s stock worth $828,883,000 after buying an additional 243,549 shares during the period. Wasatch Advisors LP increased its position in shares of HealthEquity by 3.4% in the third quarter. Wasatch Advisors LP now owns 6,307,675 shares of the company’s stock worth $597,778,000 after acquiring an additional 206,611 shares in the last quarter. AQR Capital Management LLC raised its holdings in shares of HealthEquity by 59.3% during the third quarter. AQR Capital Management LLC now owns 1,764,268 shares of the company’s stock valued at $167,200,000 after acquiring an additional 656,820 shares during the period. Westfield Capital Management Co. LP lifted its position in shares of HealthEquity by 35.7% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,716,658 shares of the company’s stock valued at $162,688,000 after acquiring an additional 451,450 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in HealthEquity by 2.5% in the 3rd quarter. Dimensional Fund Advisors LP now owns 1,559,008 shares of the company’s stock worth $147,751,000 after purchasing an additional 38,154 shares during the period. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.